NZ597024A - Cardiovascular related uses of il-1beta antibodies and binding fragments thereof - Google Patents
Cardiovascular related uses of il-1beta antibodies and binding fragments thereofInfo
- Publication number
- NZ597024A NZ597024A NZ597024A NZ59702410A NZ597024A NZ 597024 A NZ597024 A NZ 597024A NZ 597024 A NZ597024 A NZ 597024A NZ 59702410 A NZ59702410 A NZ 59702410A NZ 597024 A NZ597024 A NZ 597024A
- Authority
- NZ
- New Zealand
- Prior art keywords
- subject
- cardiovascular
- cardiovascular event
- binding fragments
- related uses
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title abstract 3
- 230000002526 effect on cardiovascular system Effects 0.000 title abstract 2
- 230000007211 cardiovascular event Effects 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 208000004476 Acute Coronary Syndrome Diseases 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000010496 Heart Arrest Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000000250 revascularization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/245—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18267909P | 2009-05-29 | 2009-05-29 | |
| US25257109P | 2009-10-16 | 2009-10-16 | |
| US31300110P | 2010-03-11 | 2010-03-11 | |
| PCT/US2010/036761 WO2010138939A1 (en) | 2009-05-29 | 2010-05-28 | CARDIOVASCULAR RELATED USES OF IL-1ß ANTIBODIES AND BINDING FRAGMENTS THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ597024A true NZ597024A (en) | 2014-01-31 |
Family
ID=43223130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ597024A NZ597024A (en) | 2009-05-29 | 2010-05-28 | Cardiovascular related uses of il-1beta antibodies and binding fragments thereof |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20100316651A1 (enExample) |
| EP (1) | EP2435073A4 (enExample) |
| JP (2) | JP5763625B2 (enExample) |
| KR (1) | KR20120061041A (enExample) |
| CN (2) | CN107243077A (enExample) |
| AU (1) | AU2010253924B2 (enExample) |
| BR (1) | BRPI1011228A2 (enExample) |
| CA (1) | CA2763161A1 (enExample) |
| EA (1) | EA201101643A1 (enExample) |
| HK (1) | HK1245111A1 (enExample) |
| IL (1) | IL216660A0 (enExample) |
| MX (1) | MX2011012666A (enExample) |
| NZ (1) | NZ597024A (enExample) |
| SG (3) | SG10201500180RA (enExample) |
| WO (1) | WO2010138939A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013025368A8 (pt) * | 2011-04-01 | 2018-06-12 | The Medicines Co | Medicamento, método para preparar um medicamento útil para reduzir danos por derrame em um sujeito com derrame, método para preparar um medicamento útil para reduzir a pressão sanguínea e reduzir danos por derrame em um sujeito com derrame |
| BR112014007253A2 (pt) * | 2011-09-30 | 2017-03-28 | Novartis Ag | uso de anticorpos que se ligam a il-1beta |
| PL2623604T3 (pl) * | 2012-02-02 | 2015-07-31 | Baylor College Medicine | Biologiczny system dostarczania i ekspresji oparty na adenowirusie do zastosowania w leczeniu choroby zwyrodnieniowej stawów |
| CN103588878A (zh) * | 2012-08-15 | 2014-02-19 | 江苏泰康生物医药有限公司 | 一种人源化抗人白细胞介素1 β单克隆抗体及其制备与应用 |
| EP4628162A3 (en) * | 2012-10-04 | 2025-12-03 | XBiotech Inc. | Treating vascular disease and complications thereof |
| US10000565B2 (en) | 2012-11-16 | 2018-06-19 | Novartis Ag | Use of IL-1 β binding antibodies for treating peripheral arterial disease |
| US10000557B2 (en) * | 2012-12-19 | 2018-06-19 | Dnae Group Holdings Limited | Methods for raising antibodies |
| CN103059136A (zh) * | 2012-12-24 | 2013-04-24 | 浙江大学 | 抗中华鳖IL-1β多克隆抗体的制备及在检测中的应用 |
| KR102337954B1 (ko) * | 2018-08-16 | 2021-12-10 | 차의과학대학교 산학협력단 | 뇌졸중 치료용 조성물 및 이를 스크리닝하는 방법 |
| CN113874034A (zh) * | 2019-05-03 | 2021-12-31 | 苏黎世大学 | 脑缺血再灌注损伤的治疗 |
| US20220275079A1 (en) * | 2020-11-20 | 2022-09-01 | The General Hospital Corporation | Clonal Hematopoiesis and Risk of Chronic Liver Disease |
| GB202400340D0 (en) | 2024-01-10 | 2024-02-21 | Wotherspoon Hugh Robert | IL-1B binding antibody |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820383B2 (en) * | 1997-03-10 | 2010-10-26 | Interleukin Genetics, Inc. | Method for diagnosing myocardial infarction |
| AR016551A1 (es) * | 1997-07-30 | 2001-07-25 | Smithkline Beecham Corp | Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos |
| US6635249B1 (en) * | 1999-04-23 | 2003-10-21 | Cenes Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
| US7860583B2 (en) * | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
| CA2440387A1 (en) * | 2001-03-23 | 2002-10-03 | Durect Corporation | Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
| US20040106954A1 (en) * | 2002-11-15 | 2004-06-03 | Whitehurst Todd K. | Treatment of congestive heart failure |
| WO2004100987A2 (en) | 2003-05-06 | 2004-11-25 | Regeneron Pharmaceuticals, Inc. | Methods of using il-1 antagonists to treat neointimal hyperplasia |
| EP1851245B1 (en) * | 2005-01-26 | 2012-10-10 | Amgen Fremont Inc. | Antibodies against interleukin-1 beta |
| US20060171948A1 (en) * | 2005-02-02 | 2006-08-03 | Weinstein Steven P | Methods of using IL-1 antagonists to reduce C-reactive protein |
| WO2006084145A2 (en) * | 2005-02-02 | 2006-08-10 | Regeneron Pharmaceuticals, Inc. | Methods of using il-1 antagonists to reduce c-reactive protein |
| AU2006236439B2 (en) | 2005-04-15 | 2012-05-03 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
| CN101228188A (zh) * | 2005-06-21 | 2008-07-23 | 佐马技术有限公司 | IL-1β结合抗体及其片段 |
| EP1940880A2 (en) * | 2005-10-14 | 2008-07-09 | Novo Nordisk A/S | Treating diabetes using inhibitors of il-1 |
| JP4524275B2 (ja) * | 2006-09-01 | 2010-08-11 | 日本ポリプロ株式会社 | ビニル基および極性基含有プロピレン系共重合体及びそれを用いる重合体の製造方法。 |
| WO2008077145A2 (en) * | 2006-12-20 | 2008-06-26 | Xoma Technology Ltd. | Treatment of il-1-beta related diseases |
-
2010
- 2010-05-28 CN CN201710537454.6A patent/CN107243077A/zh active Pending
- 2010-05-28 MX MX2011012666A patent/MX2011012666A/es active IP Right Grant
- 2010-05-28 EP EP10781360A patent/EP2435073A4/en not_active Withdrawn
- 2010-05-28 EA EA201101643A patent/EA201101643A1/ru unknown
- 2010-05-28 WO PCT/US2010/036761 patent/WO2010138939A1/en not_active Ceased
- 2010-05-28 CA CA2763161A patent/CA2763161A1/en not_active Abandoned
- 2010-05-28 CN CN2010800330317A patent/CN102573893A/zh active Pending
- 2010-05-28 BR BRPI1011228A patent/BRPI1011228A2/pt not_active IP Right Cessation
- 2010-05-28 SG SG10201500180RA patent/SG10201500180RA/en unknown
- 2010-05-28 KR KR1020117031198A patent/KR20120061041A/ko not_active Withdrawn
- 2010-05-28 SG SG2014014534A patent/SG2014014534A/en unknown
- 2010-05-28 US US12/790,738 patent/US20100316651A1/en not_active Abandoned
- 2010-05-28 JP JP2012513346A patent/JP5763625B2/ja active Active
- 2010-05-28 NZ NZ597024A patent/NZ597024A/en not_active IP Right Cessation
- 2010-05-28 AU AU2010253924A patent/AU2010253924B2/en not_active Ceased
- 2010-05-28 SG SG2011087723A patent/SG176265A1/en unknown
-
2011
- 2011-11-28 IL IL216660A patent/IL216660A0/en unknown
-
2015
- 2015-01-06 JP JP2015000602A patent/JP2015120704A/ja active Pending
-
2017
- 2017-07-11 US US15/647,203 patent/US10611832B2/en active Active
-
2018
- 2018-04-09 HK HK18104608.6A patent/HK1245111A1/zh unknown
-
2020
- 2020-02-24 US US16/799,707 patent/US20210009679A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1245111A1 (zh) | 2018-08-24 |
| AU2010253924B2 (en) | 2015-01-22 |
| WO2010138939A1 (en) | 2010-12-02 |
| US20100316651A1 (en) | 2010-12-16 |
| CA2763161A1 (en) | 2010-12-02 |
| KR20120061041A (ko) | 2012-06-12 |
| EP2435073A4 (en) | 2013-03-27 |
| SG176265A1 (en) | 2012-01-30 |
| AU2010253924A1 (en) | 2012-01-19 |
| BRPI1011228A2 (pt) | 2019-09-24 |
| JP2015120704A (ja) | 2015-07-02 |
| US20180155420A1 (en) | 2018-06-07 |
| SG2014014534A (en) | 2014-07-30 |
| SG10201500180RA (en) | 2015-03-30 |
| CN107243077A (zh) | 2017-10-13 |
| JP2012528796A (ja) | 2012-11-15 |
| EP2435073A1 (en) | 2012-04-04 |
| US20210009679A1 (en) | 2021-01-14 |
| MX2011012666A (es) | 2011-12-16 |
| IL216660A0 (en) | 2012-02-29 |
| EA201101643A1 (ru) | 2012-12-28 |
| JP5763625B2 (ja) | 2015-08-12 |
| CN102573893A (zh) | 2012-07-11 |
| US10611832B2 (en) | 2020-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ597024A (en) | Cardiovascular related uses of il-1beta antibodies and binding fragments thereof | |
| Lonardo et al. | Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome | |
| You et al. | Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | |
| NI201000034A (es) | Activadores de guanilato ciclasas solubles. | |
| RU2014132591A (ru) | Титановые сплавы | |
| JP2013501166A5 (enExample) | ||
| WO2010049678A3 (en) | Treatment of energy utilization diseases | |
| JP2011500690A5 (enExample) | ||
| BR112013032375A2 (pt) | conjugado compreendendo oxintomodulina e um fragmento de imunoglobulina, e seus usos | |
| NZ588623A (en) | Use of a medicament containing dronedarone with food for preventing cardiovascular hospitalization | |
| DE602007001036D1 (de) | Abgepacktes Konzentrat zur Zubereitung von Bouillon, Suppe, Sauce, Tunke oder zur Verwendung als Würze sowie das Konzentrat mit modifizierter Stärke | |
| WO2009057664A1 (ja) | 抗体及びその利用 | |
| Bockeria et al. | Statin therapy in the primary prevention of early atrial fibrillation after coronary artery bypass grafting | |
| JP2007510403A5 (enExample) | ||
| PH12015502100A1 (en) | Reducing the risk of autoimmune disease | |
| GT200500266A (es) | Nuevos derivados de pirimidina y su uso | |
| AR056484A1 (es) | PANEL QUE CONTIENE BAMBu | |
| PL399962A1 (pl) | Zastosowanie oleaceiny, zwlaszcza z Ligustrum vulgare L. | |
| WO2015175502A3 (en) | Replacement therapy for natriuretic peptide deficiencies | |
| WO2015039036A3 (en) | Novel cytochrome p450 inhibitors and their method of use | |
| EP2484692A4 (en) | MIMETIC APOLIPOPROTEIN A-1-PEPTIDES AND THERAPEUTICS FOR THE TREATMENT OF HYPERLIPIDEMIA AND DISEASES RELATED TO HYPERLIPIDEMIA THEREWITH | |
| Heilbron et al. | Management of atrial fibrillation in the emergency department and following acute myocardial infarction. | |
| Jang et al. | A Case of Pheochromocytoma Presenting as Stress-Induced Cardiomyopathy with Large Left Ventricular Thrombus | |
| Antz et al. | Oral anticoagulation for atrial fibrillation | |
| Kryuchkova et al. | Effectiveness of perindopril and amlodipine combination in hypertensives with COPD |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 28 MAY 2017 BY SHELSTON IP Effective date: 20140502 |
|
| ASS | Change of ownership |
Owner name: XOMA (US) LLC, US Effective date: 20150730 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2018 BY COMPUTER PACKAGES INC Effective date: 20170502 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2019 BY COMPUTER PACKAGES INC Effective date: 20180501 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2020 BY COMPUTER PACKAGES INC Effective date: 20190501 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2021 BY COMPUTER PACKAGES INC Effective date: 20200501 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2022 BY COMPUTER PACKAGES INC Effective date: 20210430 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2023 BY COMPUTER PACKAGES INC Effective date: 20220430 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 MAY 2024 BY COMPUTER PACKAGES INC Effective date: 20230430 |
|
| LAPS | Patent lapsed |